Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis

Autor: Lofland, Jennifer H., Touch, Suzanne M., O'Connor, John P., Chatterton, Mary Lou, Moxey, Elizabeth D., Paddock, Lisa E., Nash, David B., Desai, Shobhana A.
Zdroj: In Clinical Therapeutics 2000 22(11):1357-1369
Databáze: ScienceDirect